2 result(s) displayed (1 - 2 of 2):

Sanofi-Merrimack deal keeps trend alive (from Corporate Dealmaker)

Our oncology M&A list keeps growing. Sanofi-Aventis SA (NYSE:SNY), which is already on it, is acquiring the rights to sell an experimental cancer treatment developed by Merrimack Pharmaceuticals Inc. for up to $530 million. The Deal Pipeline (subscription required) has details on the transaction.The Merrimack deal comes after a setback...

Posted on October 1, 2009 2:06 PM

Bayer taps outsider as CEO, deals ahead? (from Corporate Dealmaker)

In about one year, Bayer AG's new CEO will be Thermo Fisher Scientific Inc.'s (NYSE:TMO) Marijn Dekkers. He has deal experience on a large scale, having led Thermo Electron Corp.'s $10.6 billion acquisition of Fisher Scientific International in 2006. Dekkers (pictured) will replace Werner Wenning, who held the post since...

Posted on September 15, 2009 10:23 AM